|
1
|
A Randomized Trial of Intensive versus Standard Blood-Pressure Control.
|
N Engl J Med
|
2015
|
19.14
|
|
2
|
Effect of dialysis dose and membrane flux in maintenance hemodialysis.
|
N Engl J Med
|
2002
|
10.52
|
|
3
|
FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis.
|
J Am Soc Nephrol
|
2011
|
3.52
|
|
4
|
Hemodialysis vascular access dysfunction: a cellular and molecular viewpoint.
|
J Am Soc Nephrol
|
2006
|
2.74
|
|
5
|
The association between BP and mortality in patients on chronic peritoneal dialysis.
|
Nephrol Dial Transplant
|
2005
|
2.21
|
|
6
|
Relationship between volume status and blood pressure during chronic hemodialysis.
|
Kidney Int
|
2002
|
1.93
|
|
7
|
Design of clinical trials in acute kidney injury: report from an NIDDK workshop on trial methodology.
|
Clin J Am Soc Nephrol
|
2012
|
1.90
|
|
8
|
The associations between race and geographic area and quality-of-care indicators in patients approaching ESRD.
|
Clin J Am Soc Nephrol
|
2013
|
1.87
|
|
9
|
Impact of timing of initiation of dialysis on mortality.
|
J Am Soc Nephrol
|
2003
|
1.73
|
|
10
|
Creatinine production, nutrition, and glomerular filtration rate estimation.
|
J Am Soc Nephrol
|
2003
|
1.57
|
|
11
|
Inhibition of neointimal hyperplasia in vascular grafts by sustained perivascular delivery of paclitaxel.
|
Kidney Int
|
2004
|
1.56
|
|
12
|
Both low muscle mass and low fat are associated with higher all-cause mortality in hemodialysis patients.
|
Kidney Int
|
2010
|
1.55
|
|
13
|
Lipoprotein metabolism and lipid management in chronic kidney disease.
|
J Am Soc Nephrol
|
2007
|
1.53
|
|
14
|
Disordered mineral metabolism in hemodialysis patients: an analysis of cumulative effects in the Hemodialysis (HEMO) Study.
|
Am J Kidney Dis
|
2008
|
1.46
|
|
15
|
Kinetic model of phosphorus mobilization during and after short and conventional hemodialysis.
|
Clin J Am Soc Nephrol
|
2011
|
1.45
|
|
16
|
OPPORTUNITY™: a large-scale randomized clinical trial of growth hormone in hemodialysis patients.
|
Nephrol Dial Transplant
|
2011
|
1.44
|
|
17
|
The relationship of age, race, and ethnicity with survival in dialysis patients.
|
Clin J Am Soc Nephrol
|
2013
|
1.32
|
|
18
|
Duration of end-stage renal disease and kidney transplant outcome.
|
Nephrol Dial Transplant
|
2004
|
1.28
|
|
19
|
Serum alkaline phosphatase and mortality in African Americans with chronic kidney disease.
|
Clin J Am Soc Nephrol
|
2009
|
1.23
|
|
20
|
Cellular and morphological changes during neointimal hyperplasia development in a porcine arteriovenous graft model.
|
Nephrol Dial Transplant
|
2007
|
1.22
|
|
21
|
Design of clinical trials in acute kidney injury: a report from an NIDDK workshop--prevention trials.
|
Clin J Am Soc Nephrol
|
2012
|
1.20
|
|
22
|
Patient preferences for in-center intense hemodialysis.
|
Hemodial Int
|
2005
|
1.20
|
|
23
|
Neointimal hyperplasia associated with synthetic hemodialysis grafts.
|
Kidney Int
|
2008
|
1.18
|
|
24
|
Intradialytic hypotension and vascular access thrombosis.
|
J Am Soc Nephrol
|
2011
|
1.17
|
|
25
|
Blood pressure in chronic kidney disease stage 5D-report from a Kidney Disease: Improving Global Outcomes controversies conference.
|
Kidney Int
|
2009
|
1.16
|
|
26
|
Cerebrovascular disease in maintenance hemodialysis patients: results of the HEMO Study.
|
Am J Kidney Dis
|
2006
|
1.14
|
|
27
|
Design of clinical trials in AKI: a report from an NIDDK workshop. Trials of patients with sepsis and in selected hospital settings.
|
Clin J Am Soc Nephrol
|
2012
|
1.13
|
|
28
|
Associations of metabolic syndrome with inflammation in CKD: results From the Third National Health and Nutrition Examination Survey (NHANES III).
|
Am J Kidney Dis
|
2005
|
1.09
|
|
29
|
Association of obesity with inflammation in chronic kidney disease: a cross-sectional study.
|
J Ren Nutr
|
2004
|
1.07
|
|
30
|
Predictors of sudden cardiac death: a competing risk approach in the hemodialysis study.
|
Clin J Am Soc Nephrol
|
2011
|
1.07
|
|
31
|
Associations of plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D concentrations with death and progression to maintenance dialysis in patients with advanced kidney disease.
|
Am J Kidney Dis
|
2012
|
1.05
|
|
32
|
Association of serum albumin and atherosclerosis in chronic hemodialysis patients.
|
Am J Kidney Dis
|
2002
|
1.03
|
|
33
|
Racial differences in markers of mineral metabolism in advanced chronic kidney disease.
|
Clin J Am Soc Nephrol
|
2012
|
1.03
|
|
34
|
Serum bicarbonate and mortality in adults in NHANES III.
|
Nephrol Dial Transplant
|
2013
|
1.02
|
|
35
|
Longitudinal assessment of hyperplasia using magnetic resonance imaging without contrast in a porcine arteriovenous graft model.
|
Acad Radiol
|
2009
|
1.00
|
|
36
|
Differential effects of imatinib on PDGF-induced proliferation and PDGF receptor signaling in human arterial and venous smooth muscle cells.
|
J Cell Biochem
|
2006
|
0.99
|
|
37
|
PDGF-induced proliferation in human arterial and venous smooth muscle cells: molecular basis for differential effects of PDGF isoforms.
|
J Cell Biochem
|
2011
|
0.96
|
|
38
|
Impact of renal failure on the risk of myocardial infarction and death.
|
Kidney Int
|
2002
|
0.96
|
|
39
|
Associations of serum skeletal alkaline phosphatase with elevated C-reactive protein and mortality.
|
Clin J Am Soc Nephrol
|
2012
|
0.94
|
|
40
|
Inflammation and inverse associations of body mass index and serum creatinine with mortality in hemodialysis patients.
|
J Ren Nutr
|
2007
|
0.93
|
|
41
|
The association of lipid levels with mortality in patients on chronic peritoneal dialysis.
|
Nephrol Dial Transplant
|
2006
|
0.93
|
|
42
|
β-Blockers for prevention of sudden cardiac death in patients on hemodialysis: a propensity score analysis of the HEMO Study.
|
Am J Kidney Dis
|
2011
|
0.92
|
|
43
|
The role of pretransplantation renal replacement therapy modality in kidney allograft and recipient survival.
|
Am J Kidney Dis
|
2005
|
0.91
|
|
44
|
Hollow fiber shape alters solute clearances in high flux hemodialyzers.
|
ASAIO J
|
2003
|
0.91
|
|
45
|
Development of a sustained-release system for perivascular delivery of dipyridamole.
|
J Biomed Mater Res B Appl Biomater
|
2006
|
0.89
|
|
46
|
Serum alkaline phosphatase levels associate with elevated serum C-reactive protein in chronic kidney disease.
|
Kidney Int
|
2010
|
0.89
|
|
47
|
Risk factors for sudden cardiac death in patients with chronic renal insufficiency and left ventricular dysfunction.
|
Am J Nephrol
|
2007
|
0.89
|
|
48
|
Serial analysis of lumen geometry and hemodynamics in human arteriovenous fistula for hemodialysis using magnetic resonance imaging and computational fluid dynamics.
|
J Biomech
|
2012
|
0.89
|
|
49
|
Dialyzer performance in the HEMO Study: in vivo K0A and true blood flow determined from a model of cross-dialyzer urea extraction.
|
ASAIO J
|
2004
|
0.87
|
|
50
|
Dialyzer membranes as determinants of the adequacy of dialysis.
|
Semin Nephrol
|
2005
|
0.87
|
|
51
|
Perivascular tissue pharmacokinetics of dipyridamole.
|
Pharm Res
|
2006
|
0.87
|
|
52
|
Evaluation of histological techniques for quantifying haemodialysis arteriovenous (AV) graft hyperplasia.
|
Nephrol Dial Transplant
|
2006
|
0.86
|
|
53
|
Volume indicators and left ventricular mass during aggressive volume management in patients on thrice-weekly hemodialysis.
|
Nephron Clin Pract
|
2009
|
0.86
|
|
54
|
A population-based assessment of the familial component of chronic kidney disease mortality.
|
Am J Nephrol
|
2006
|
0.86
|
|
55
|
Soluble epoxide hydrolase expression in a porcine model of arteriovenous graft stenosis and anti-inflammatory effects of a soluble epoxide hydrolase inhibitor.
|
Am J Physiol Cell Physiol
|
2012
|
0.86
|
|
56
|
Kinetics of urea and beta-microglobulin during and after short hemodialysis treatments.
|
Kidney Int
|
2004
|
0.86
|
|
57
|
Measurement of renal tissue oxygenation with blood oxygen level-dependent MRI and oxygen transit modeling.
|
Am J Physiol Renal Physiol
|
2014
|
0.86
|
|
58
|
A biodegradable perivascular wrap for controlled, local and directed drug delivery.
|
J Control Release
|
2012
|
0.85
|
|
59
|
A crossover study of short daily haemodialysis.
|
Nephrol Dial Transplant
|
2005
|
0.85
|
|
60
|
Valsartan slows the progression of diabetic nephropathy in db/db mice via a reduction in podocyte injury, and renal oxidative stress and inflammation.
|
Clin Sci (Lond)
|
2014
|
0.85
|
|
61
|
Thermal sensitivity of endothelial cells on synthetic vascular graft material.
|
Int J Hyperthermia
|
2012
|
0.85
|
|
62
|
Efficacy and safety of carvedilol in treatment of heart failure with chronic kidney disease: a meta-analysis of randomized trials.
|
Circ Heart Fail
|
2010
|
0.84
|
|
63
|
In-vitro Release of Rapamycin from a Thermosensitive Polymer for the Inhibition of Vascular Smooth Muscle Cell Proliferation.
|
J Bioequiv Availab
|
2009
|
0.84
|
|
64
|
Correlation of tissue drug concentrations with in vivo magnetic resonance images of polymer drug depot around arteriovenous graft.
|
J Control Release
|
2010
|
0.84
|
|
65
|
In vivo evaluation of the delivery and efficacy of a sirolimus-laden polymer gel for inhibition of hyperplasia in a porcine model of arteriovenous hemodialysis graft stenosis.
|
J Control Release
|
2012
|
0.83
|
|
66
|
Different responses by cultured aortic and venous smooth muscle cells to gamma radiation.
|
Kidney Int
|
2005
|
0.82
|
|
67
|
Arterial and venous smooth-muscle cells differ in their responses to antiproliferative drugs.
|
J Lab Clin Med
|
2004
|
0.82
|
|
68
|
Improving outcomes in CKD and ESRD patients: carrying the torch from training to practice.
|
Semin Dial
|
2004
|
0.81
|
|
69
|
Mechanism of dipyridamole's action in inhibition of venous and arterial smooth muscle cell proliferation.
|
Basic Clin Pharmacol Toxicol
|
2006
|
0.81
|
|
70
|
The association of lipid-modifying medications with mortality in patients on long-term peritoneal dialysis.
|
Am J Kidney Dis
|
2007
|
0.80
|
|
71
|
Angiotensin-converting enzyme inhibitors and cardiovascular outcomes in patients on maintenance hemodialysis.
|
Am Heart J
|
2011
|
0.80
|
|
72
|
Low body mass index and dyslipidemia in dialysis patients linked to elevated plasma fibroblast growth factor 23.
|
Am J Nephrol
|
2013
|
0.80
|
|
73
|
Special considerations for antihypertensive agents in dialysis patients.
|
Blood Purif
|
2010
|
0.79
|
|
74
|
Revisiting the hemodialysis dose.
|
Semin Dial
|
2006
|
0.79
|
|
75
|
The HEMO Study: applicability and generalizability.
|
Nephrol Dial Transplant
|
2004
|
0.79
|
|
76
|
Lack of synergistic effects of metabolic syndrome and plasma fibrinogen on coronary events and mortality in moderate CKD.
|
Am J Kidney Dis
|
2007
|
0.79
|
|
77
|
Higher fibroblast growth factor-23 concentrations associate with left ventricular systolic dysfunction in dialysis patients.
|
Clin Nephrol
|
2013
|
0.79
|
|
78
|
Effect of membrane permeability on survival of hemodialysis patients.
|
J Am Soc Nephrol
|
2009
|
0.79
|
|
79
|
Facility size, race and ethnicity, and mortality for in-center hemodialysis.
|
J Am Soc Nephrol
|
2013
|
0.78
|
|
80
|
Familiality of cardiovascular mortality in end-stage renal disease patients.
|
Am J Nephrol
|
2008
|
0.78
|
|
81
|
Expression of C-reactive protein in myointimal hyperplasia in a porcine arteriovenous graft model.
|
Nephrol Dial Transplant
|
2007
|
0.78
|
|
82
|
Elevated fibrinogen fragment levels in uremic plasma inhibit platelet function and expression of glycoprotein IIb-IIIa.
|
Am J Hematol
|
2006
|
0.78
|
|
83
|
The role of pre-emptive re-transplant in graft and recipient outcome.
|
Nephrol Dial Transplant
|
2006
|
0.78
|
|
84
|
OPPORTUNITY: a randomized clinical trial of growth hormone on outcome in hemodialysis patients.
|
Clin J Am Soc Nephrol
|
2008
|
0.78
|
|
85
|
25-vitamin D, 1,25-vitamin D, parathyroid hormone, fibroblast growth factor-23 and cognitive function in men with advanced CKD: a veteran population.
|
Clin Nephrol
|
2014
|
0.78
|
|
86
|
Different signaling responses to anti-proliferative agents in human aortic and venous smooth muscle cells.
|
J Cell Biochem
|
2006
|
0.77
|
|
87
|
Does statin therapy improve cardiovascular outcomes in patients with type 2 diabetes receiving hemodialysis?
|
Nat Clin Pract Nephrol
|
2006
|
0.77
|
|
88
|
Computer simulation of small-solute and middle-molecule removal during short daily and long thrice-weekly hemodialysis.
|
Am J Kidney Dis
|
2002
|
0.76
|
|
89
|
A simple method to estimate phosphorus mobilization in hemodialysis using only predialytic and postdialytic blood samples.
|
Hemodial Int
|
2011
|
0.76
|
|
90
|
Modelling ultrasound-induced mild hyperthermia of hyperplasia in vascular grafts.
|
Theor Biol Med Model
|
2011
|
0.75
|
|
91
|
25-hydroxyvitamin D deficiency is associated with an increased risk of metabolic syndrome in patients with non-diabetic chronic kidney disease.
|
Clin Nephrol
|
2012
|
0.75
|
|
92
|
Using the stochastic collocation method for the uncertainty quantification of drug concentration due to depot shape variability.
|
IEEE Trans Biomed Eng
|
2008
|
0.75
|
|
93
|
Blood pressure control in type 2 diabetes mellitus.
|
Am J Kidney Dis
|
2010
|
0.75
|
|
94
|
Aberrant soluble epoxide hydrolase and oxylipin levels in a porcine arteriovenous graft stenosis model.
|
J Vasc Res
|
2014
|
0.75
|
|
95
|
Implications of the Frequent Hemodialysis Network-Daily Trial.
|
Semin Dial
|
2011
|
0.75
|
|
96
|
Cellular pharmacokinetics and pharmacodynamics of dipyridamole in vascular smooth muscle cells.
|
Biochem Pharmacol
|
2006
|
0.75
|
|
97
|
Misoprostol effects on diclofenac-induced cardiorenal changes in salt-sensitive patients with hypertension: the MEDIC Study.
|
Pharmacotherapy
|
2008
|
0.75
|
|
98
|
In vitro pharmacological inhibition of human vascular smooth muscle cell proliferation for the prevention of hemodialysis vascular access stenosis.
|
Blood Purif
|
2004
|
0.75
|
|
99
|
The career of Lee W. Henderson.
|
J Am Soc Nephrol
|
2002
|
0.75
|
|
100
|
Optimal use of hemodialyzers.
|
Contrib Nephrol
|
2002
|
0.75
|
|
101
|
Mineral Metabolites, Angiotensin II Inhibition and Outcomes in Advanced Chronic Kidney Disease.
|
Am J Nephrol
|
2015
|
0.75
|